BeiGene obtains certain rights for Leap Therapeutics cancer drug
Chinese biopharmaceutical firm BeiGene has agreed to exclusive rights to develop and commercialise Leap Therapeutics’...
Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory...
Arena Pharmaceuticals, Inc. and Beacon Discovery announced that they entered into a strategic multi-year partnership...
Vaccitech partners with CRUK on NSCLC immunotherapeutic vaccine
Vaccitech has signed a partnership with Cancer Research UK (CRUK) to clinically advance VTP-600, the...
Aptar Pharma to Highlight Drug Delivery Solutions Portfolio and Expanded Services Offering at Pharmapack...
Aptar Pharma, a global leader in drug delivery systems and active packaging solutions, announces that...
Novartis and Forendo enter into tissue hormone focused licensing collaboration
Finland-based Forendo Pharma has announced it has signed a licensing and collaboration agreement with Novartis.
The...
MedPharm moves into $4M expansion of its North Carolina facility
MedPharm, the leader in topical and transdermal drug delivery, has moved into its newly expanded...
Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic...
PCI Pharma Services Announces Major Investment to Expand Development and Manufacturing Capabilities at Tredegar,...
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced it...
Spotlight on Abzena’s Developability Platform during Antibody Engineering & Therapeutics 2019
Abzena is showcasing its new Developability Service, enabling biotechnology and pharmaceutical companies to improve lead...
Big pharma agrees to drastically cut prices of blockbuster drugs in China
China’s National Healthcare Security Administration (NHSA) has announced it has agreed an average 61% cut...